In a earlier article, I highlighted the biggest pharmacy chains that can take part within the 2024 Medicare Half D prescription drug plans (PDP).
In the present day, I replace DCI’s unique evaluation of how smaller pharmacies will take part as most popular price sharing pharmacies through the pharmacy providers administrative organizations (PSAOs) that signify them in negotiations with plans.
As you will notice under, the biggest PSAOs have successfully deserted PDP’s most popular networks in 2024. Plans from Aetna, Humana, WellCare, and UnitedHealthcare is not going to have any unbiased pharmacies collaborating through PSAOs as most popular pharmacies.
Smaller pharmacies’ potential to navigate away gives extra dangerous information for stand-alone Half D market—and one other surprising consequence of the Inflation Discount Act of 2022. Look out under!
PART D IN 2024
That is our third article in regards to the 2024 Medicare Half D market. Listed here are the primary two within the collection:
For a deep dive into the economics and methods of slender community fashions in each authorities and business plans, see Chapter 7 of our Financial Report on U.S. Pharmacies and Pharmacy Profit Managers.
MAKE ME AN OFFER
Giant pharmacies work together and negotiate immediately with PBMs and different third-party payers. Nonetheless, practically all smaller pharmacy homeowners take part in pharmacy providers administrative organizations (PSAOs) to leverage their affect in contract negotiations with PBMs and different third-party payers. The PSAO relationship is essential for unbiased pharmacies, as a result of independents generate greater than 90% of their complete gross sales from prescription meting out.
Listed here are the biggest PSAOs:
- Cardinal Well being operates three PSAOs that serve totally different segments of its enterprise. LeaderNET providers Cardinal’s drug distribution clients and is the biggest of its PSAOs.
- AlignRx was fashioned from the 2021 merger of Arete Pharmacy Community (owned by American Related Pharmacies) with PPOk (owned by Unify Rx). AlignRx is the biggest PSAO that’s not owned by a wholesaler. Because of the merger, AlignRx now has three separate networks: Align Rx APN (the brand new identify for the legacy Arete community); Align Rx RxSelect; and Align Rx TriNet.
For our newest information on PSAOs and their providers (together with a listing of the highest PSAOs ranked by membership), see Part 2.2.4. of our Financial Report on Pharmaceutical Wholesalers and Specialty Distributors.
NEVER MIND
To enhance our analyses of retail chains, the desk under summarizes the popular community standing of pharmacy members that belong to the 4 largest PSAOs. The inexperienced shaded packing containers point out the PSAO members’ addition as most popular pharmacies to a 2024 community (vs. 2023). The crimson shaded packing containers point out the PSAO members’ elimination as most popular pharmacies from a 2024 community (vs. 2023). Click on right here to obtain the desk as a PDF.
[Click to Enlarge]
Listed here are highlights of PSAO participation in 2024 Half D most popular networks:
- For 2024, McKesson’s Well being Mart Atlas (HMA) is immediately collaborating in solely two of Cigna’s three plans. Its members can contract immediately with 4 different plans. Every PSAO member can select to take part as a most popular vs. a typical price sharing pharmacy for 2024. (Within the desk above, that is indicated by the superscript “1.”)
In any other case, HMA members is not going to be most popular. An HMA spokesperson informed me that it’s “centered on securing the best contracts to primarily non-preferred networks to steadiness affected person entry and the financial viability of the pharmacies it serves.”
Recall that as just lately as 2021, HMA members had most popular standing similar to the participation of the biggest chains.
- Cencora’s Elevate continues to consider that sufferers decide their pharmacy after which decide their Half D plan. For the seventh consecutive yr, its members is not going to be most popular in any main plan.
An Elevate spokesperson informed me that “our information continues to validate our strategy.” They shared that year-over-year prescription progress (via September 2023) amongst Elevate PSAO members was +6.3%, in contrast with progress of solely +1.7% for the entire retail market. (I used to be unable to confirm these figures, however they’re in keeping with Elevate’s earlier disclosures.) It most likely helps that Cencora’s Good Neighbor Pharmacy scored increased than its friends and enormous retail chains in the newest J.D. Energy U.S. Pharmacy Examine.
- AlignRx. For 2024, none of AlignRx’s three PSAOs—AlignRx APN, RxSelect and Trinet—can have most popular standing in any main stand-alone Half D plan. For plans from Cigna, Humana, and Mutual of Omaha, its members can contract immediately with the plans for most popular standing.
Regardless of the low engagement with most popular plans, smaller pharmacies profit from three essential Half D dynamics:
- Beneficiaries who qualify for the Low-Earnings Subsidy (LIS) face low out-of-pocket drug prices no matter a pharmacy’s most popular standing. Due to the Inflation Discount Act of 2022, the variety of LIS-eligible beneficiaries will enhance.
- As I described in Development #10 of my Drug Channels Outlook 2024 video webinar, premiums for the biggest stand-alone PDPs jumped for 2024—which is able to set off additional enrollment losses for this Half D possibility.
I doubt the homeowners of smaller pharmacies will remorse saying nope to most popular standing in a collapsing PDP market.
